You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.
You have previously recommended Challenger for both its strong position in the annuities market for the future and its relatively high dividend yield.
I previously bought at around $10.80. With its recent decline now to $6.50 per share, would you recommend buying some more, particularly with dividend yield now around 5.5%?
A: I got Challenger wrong and cut if from our growth portfolio at the end of May. I feel a little burnt. Clearly, the market also got it wrong, not seeing the impact of ultra-low interest rates and the Royal Commission on annuity sales by planners.
I am loathe to give you an opinion.
As for the market, according to FN Arena, there is 1 buy recommendation, 6 neutral recommendations, and 1 sell recommendation. The consensus target price is $7.27, about 12% higher than the current market price. The broker range is a low of $6.52 to a high of $8.80. Mike McCarthy wrote positively about Challenger in yesterday’s Switzer Report.
